AcuCort receives a granted patent in Canada for the company's drug Zeqmelit™
AcuCort AB (publ) (Spotlight Stock Market: ACUC) today announces that the Canadian Intellectual Property Office, CIPO, has granted a patent for AcuCort's drug Zeqmelit™. The patent protection covers the oral film technology with steroids that enables a user-friendly form of administration for the patient.The positive decision from the Canadian Intellectual Property Office means that the oral film technology with steroids used in AcuCort's approved drug Zeqmelit™ has patent protection. The drug’s name was formerly ISICORT. The Canadian patent is co-owned with AcuCort's former manufacturing